Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review

Abstract Background Treatment beyond progression with immunotherapy may be appropriate in selected patients based on the potential for late responses. The aim of this systematic review was to explore the impact of treatment beyond progression in patients receiving an anti-PD-1/PD-L1 based regimen fo...

Full description

Bibliographic Details
Main Authors: Francesco Spagnolo, Andrea Boutros, Federica Cecchi, Elena Croce, Enrica Teresa Tanda, Paola Queirolo
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-08165-0